NCT05829928View on ClinicalTrials.gov

Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Gender DysphoriaTransgender
Interventions
DIAGNOSTIC_TEST

Infectious Disease Testing

Participants will undergo infectious disease testing.

PROCEDURE

Gonadal Tissue Removal

Removal of gonadal tissue will be done through a surgical procedure.

Trial Locations (1)

15213

Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT05829928 - Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy | Biotech Hunter | Biotech Hunter